This inventor holds 2 USPTO granted patents. Top assignees: The General Hospital Corporation, Duke University. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 1996
Title: Michael Gustafson: Innovator in Molecular Biology
Introduction
Michael Gustafson is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of molecular biology, particularly in the area of receptor encoding. With a total of 2 patents, his work has advanced our understanding of various biological processes.
Latest Patents
Gustafson's latest patents include groundbreaking innovations such as DNA encoding a receptor for Mullerian inhibitory substance, misr1. Additionally, he has developed isolated DNAs, including cDNAs or genomic fragments, that encode MIS receptors, inhibin receptors, and bone morphogenic protein receptors. These patents also cover vectors or cells containing such DNAs and substantially pure polypeptides encoded by these DNAs, produced through various methods including expression, isolation from natural sources, or chemical synthesis. Another significant patent involves nucleic acids encoding a TGF-.beta. type 1 receptor, which also includes isolated DNAs and their applications.
Career Highlights
Throughout his career, Michael Gustafson has worked with prestigious institutions such as The General Hospital Corporation and Duke University. His work in these organizations has allowed him to contribute to important research and development in the field of molecular biology.
Collaborations
Gustafson has collaborated with esteemed colleagues, including Patricia K. Donahoe and Wei-Wu He. These partnerships have further enriched his research and innovation efforts.
Conclusion
Michael Gustafson's contributions to molecular biology through his patents and collaborations highlight his role as an influential inventor in the scientific community. His work continues to impact the understanding of biological receptors and their functions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile